Fowler Eyes New Favored-Nation Approach, But Waits For Congress

By John Wilkerson / June 4, 2021 at 12:47 PM
CMS’ innovation center likely will take a different approach to the drug pricing favored-nation demo attempted by the Trump administration and now delayed by the courts, Center for Medicare and Medicaid Innovation Director Elizabeth Fowler said Thursday (June 3). The drug industry shouldn't expect the Biden administration to take its foot off the gas on drug pricing, she said, but the administration wants to see what Congress does before undertaking drug-pricing demos. The favored nation demonstration is the Trump administration’s...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.